The global autacoids and related drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Autacoids are defined as the biological elements that work similar to hormones and are permeated by the body cells in response to various types of stimulations. The simulations are carried out to prompt physiological responses such as treatment of a local injury or other ailments. Any discrepancy in the synthesis, release or transduction system related to these temporarily formed biological factors triggers pathological conditions such as allergy, inflammation, and hypersensitivity. Autacoids antagonists are prescribed for the prevention of such undesirable changes to the body in response to an imbalance in the operation of autacoids. The global autacoids and related drugs market growth is majorly attributed to the growing cases of chronic pain all over the globe.

Rising research and development activities that involve the use of autacoids as potential therapeutic immunomodulators for a variety of disease conditions are likely to drive the global autacoids and related drugs market in the future years. In addition to this, the growing interest in the use of lipid autacoids as key therapeutic agents for treating chronic pain will also be another key factor driving the market. The significant rise in cases of chronic pain across the globe and the increased focus of the medical community on the severity of chronic pain and finding effective ways to treat it are expected to make lipid autacoids a key drug candidate for the condition in the near future.

Some key players operating in the market include Bristol-Myers Squibb Co., and Abbott Laboratories, among others. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships and collaborations, and new product launches and development in the existing product portfolio, and so on.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Type
• By Application

Regions covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape:  Bristol-Myers Squibb Co., and Abbott Laboratories, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Autacoids and Related Drugs Market Report by Segment

By Type

• Polypeptides
• Decarboxylated Amino Acid
• Eicosanoids

By Application

• Allergies 
• Inflammation 
• Gastric Acid Secretion
• Neuroendocrine Regulation
• Chronic Pain
• Cardiovascular Diseases
• Gastrointestinal Diseases

Global Autacoids and Related Drugs Market Report by Region

North America       

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific    

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa